GENEVA, Aug. 14 -- KINIKSA PHARMACEUTICALS, GMBH filed a patent application (IB2026/051174) for “TREATMENT OF RECURRENT PERICARDITIS BY DELIVERY OF ANTI-INTERLEUKIN-1 RECEPTOR ANTIBODY”. With publication no. WO/2026/167629, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....